Form D · Other Technology
ProteoSense LLC
Columbus, OH · CIK 0001720473
Offering snapshot reported Oct 24, 2017 · SEC filing
- Reported sold
- $482K Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Sep 15, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2017 | Initial | $482,218 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-297325
Convertible Promissory Note and the applicable underlying limited liability membership units
Source: Form D, filed Oct 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Bates | Executive |
| Brad Beasecker | Director, Executive |
| Mark Byrne | Director, Executive |
| Mark Keszenheimer | Director |
| Chris Littel | Executive |
| Daniel Wampler | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1275 Kinnear Road
Columbus, OH, 43212
Columbus, OH, 43212